Skip to main content

Table 1 Baseline patient characteristics (n = 34)

From: Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

Age Mean (SD)

64 (8)

Characteristics

No. (%)

Gender

 Male

33 (97)

 Female

1 (3)

T Stage at diagnosis

 T3

25 (73.5)

 < T3

7 (20.5)

 Unknown

2 (6)

N Stage at Diagnosis

 0

9 (26.5)

 1

10 (29)

 2

7 (20.5)

 3

4 (12)

 Unknown

4 (12)

Resection Margin (R0)

 Yes

31 (91)

 No

3 (9)

Neoadjuvant Treatment

 Carboplatin, Paclitaxel and Radiation

21 (62)

 Other

13 (38)

Radiation Dose

 ≤ 4140 cGy

4 (12)

 > 4140 cGy

22 (59)

 Unknown

2 (6)

 None

6 (24)

Pathologic Response

 Stable Disease

5 (15)

 Partial Response

11 (29)

 Progressive Disease

3 (9)

 Complete Response

15 (41)

Recurrence

 Yes

19 (56)

 No

15 (44)

Mortality

 Alive

18 (53)

 Deceased

16 (47)

Type of Surgery

 Minimally Invasive Esophagectomy

29 (85)

 Other

5 (15)

Age Mean (SD)

64 (8)